About the Editors

Editor-in-Chief
Brian Kelsall, MD
Dr. Kelsall is currently a tenured scientist and head of the Mucosal Immunobiology Section of the Laboratory of Molecular Immunology in the NIAID at the NIH in Bethesda, Maryland. Dr. Kelsall received formal training in Medicine at Case Western Reserve University School of Medicine, and completed a residency in Internal Medicine at the New York Hospital and a fellowship in Infectious Diseases at the University of Virginia. He completed a post-doctoral fellowship in mucosal immunology with Warren Strober before establishing his own laboratory at the NIH in 1995. His research is focused on the regulation of immune responses in the intestine, in particular the role of dendritic cell populations in the induction and regulation of mucosal tolerance and immunity. He is currently exploring dendritic cell function in innate and adaptive immunity to intestinal viral infection and in the pathogenesis of inflammatory bowel disease. His laboratory also studies the molecular mechanisms that regulate the production of cytokines important for directing the differentiation of T cell responses by dendritic cells and macrophages. The primary goals of his research are to develop novel mucosal vaccines and therapies for inflammatory bowel disease. Dr. Kelsall has been an active member of the Society for Mucosal Immunology (SMI) for the past 12 years, and has been a member of the SMI editorial board and an elected member of the SMI governing council. Dr. Kelsall is also currently a member of the American Association of Immunologists (AAI), the Infectious Disease Society of America (IDSA), and the American Society for Clinical Investigation (ASCI). He has received numerous honors and awards, and has published over 65 research articles, reviews, commentaries and chapters.

Deputy Editors
Paul Garside, PhD
Dr. Garside is the Director for Biophotonics at the University of Strathclyde and a Visiting Professor in Division Immunology, Infection & Inflammation at the University of Glasgow. He received a BSc from the University of Salford, UK and a PhD on intestinal helminths from the University of Nottingham, UK. He completed a Wellcome Trust Career Development Fellowship at the University of Glasgow, UK, where he later became a Professor of Immunobiology. Dr. Garside's research centers on understanding immunoregulation by tracking cellular and molecular interactions in vivo with a view to improving therapy for autoimmune and inflammatory disorders and the design and use of vaccines. Investigating immunological events in vivo and developing the technology to do so has resulted in studies examining lymphocyte and APC interactions in a variety of scenarios and have provided information on how TH1 and TH2 responses develop, the mechanisms and efficacy of DNA vaccination, the impact of infection on immune responsiveness and the regulation of autoimmunity. More recently, he has been involved in studies employing multiphoton microscopy to show the real time interactions of antigen-specific T cells during the development if immune responses in vivo. He has been a member of the SMI editorial board and an elected member of the SMI governing council. Also member of British Society for Immunology (BSI).

Jo Viney, PhD
Dr. Viney leads a department of 50+ scientists at Amgen Washington researching autoimmune and inflammatory diseases. The mission of the group is to drive the discovery and development of novel therapeutics that will improve the health of patients with autoimmune and inflammatory diseases including IBD, asthma, MS, Lupus, RA, psoriasis and fibrosis. The interests of Dr. Viney's research team revolve around modulation of intestinal immune responses. Most recently, her group has focused on the identification and characterization a novel B7 family member expressed in mucosal tissues that functions to negatively regulate T cells. Other interests include the investigation of the mechanistic basis of inflammatory bowel disease with emphasis on the validation of potential therapeutics, and the modulation of immune responses via dendritic cell modulation. Dr. Viney has been at Amgen (formerly Immunex) for almost 12 years. Prior to joining the company, she completed postdoctoral fellowships at Genentech in San Francisco and the Imperial Cancer Research Fund in London. She received her doctorate degree from St Bartholomew's Hospital at the University of London. She has more than 50 publications in the field of inflammation. She is a member of the American Association of Immunologists (AAI) and an elected Councilor for the Society for Mucosal Immunology (SMI).